Kymera Therapeutics (NASDAQ:KYMR) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Kymera Therapeutics missed estimated earnings by 2.94%, reporting an EPS of $-0.7 versus an estimate of $-0.68.
Revenue was down $156 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 5.13% drop in the share price the next day.
Here’s a look at Kymera Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.63 | -0.74 | -0.72 | -0.66 |
| EPS Actual | -0.60 | -0.79 | -0.78 | -0.71 |
| Revenue Estimate | 21.58M | 15.51M | 13.84M | 16.23M |
| Revenue Actual | 16.14M | 9.55M | 11.51M | 9.62M |
To track all earnings releases for Kymera Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
